• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β1与前列腺癌的关联:一项免疫组织化学研究。

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.

作者信息

Truong L D, Kadmon D, McCune B K, Flanders K C, Scardino P T, Thompson T C

机构信息

Department of Pathology, Methodist Hospital, Houston, TX.

出版信息

Hum Pathol. 1993 Jan;24(1):4-9. doi: 10.1016/0046-8177(93)90055-l.

DOI:10.1016/0046-8177(93)90055-l
PMID:7678092
Abstract

Prostate tissue samples from patients with prostatic carcinoma (PC) and/or benign prostatic hyperplasia (BPH) were examined for expression of transforming growth factor-beta 1 (TGF-beta 1) using an immunohistochemical technique. Tissues were stained with CC and LC antisera, which react with extracellular and intracellular TGF-beta 1, respectively. All PC and BPH tissues showed positive extracellular staining; however, CC-immunoreactive material was significantly more extensive in PC compared with BPH, the average positively staining areas being 59% and 26%, respectively. This differential staining pattern was evident in cases in which areas of PC were located adjacent to areas of BPH. LC staining was identified exclusively intracellularly involving both stromal and epithelial cells in cases of PC as well as BPH. However, while stromal cell staining was more pronounced in BPH, epithelial cell staining tended to be more extensive and more intense in PC. The findings suggest that TGF-beta 1 may be biologically important in the development of PC and BPH.

摘要

采用免疫组织化学技术检测前列腺癌(PC)和/或良性前列腺增生(BPH)患者的前列腺组织样本中转化生长因子β1(TGF-β1)的表达。组织分别用CC和LC抗血清染色,它们分别与细胞外和细胞内的TGF-β1反应。所有PC和BPH组织均显示细胞外染色阳性;然而,与BPH相比,PC中CC免疫反应性物质明显更广泛,平均阳性染色面积分别为59%和26%。在PC区域与BPH区域相邻的病例中,这种差异染色模式很明显。LC染色仅在细胞内发现,在PC和BPH病例中均涉及基质细胞和上皮细胞。然而,虽然BPH中基质细胞染色更明显,但PC中上皮细胞染色往往更广泛、更强烈。这些发现表明,TGF-β1可能在PC和BPH的发生发展中具有重要生物学意义。

相似文献

1
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.转化生长因子-β1与前列腺癌的关联:一项免疫组织化学研究。
Hum Pathol. 1993 Jan;24(1):4-9. doi: 10.1016/0046-8177(93)90055-l.
2
Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.转化生长因子β1及其I型和II型受体。在人正常前列腺、良性前列腺增生和前列腺癌中的比较。
Growth Factors. 1998;16(2):101-10. doi: 10.3109/08977199809002121.
3
Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.转化生长因子β1与前列腺肿瘤中的雄激素受体
Anal Quant Cytol Histol. 2000 Oct;22(5):403-10.
4
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.转化生长因子-β1:在人原发性和转移性前列腺癌中的比较免疫组织化学定位
Lab Invest. 1995 Nov;73(5):628-35.
5
Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.人良性、癌前和恶性前列腺组织中细胞凋亡发生率以及p53、转化生长因子-β受体II、p27Kip1和Smad4的蛋白表达
Hum Pathol. 2004 Mar;35(3):290-7. doi: 10.1016/j.humpath.2003.11.001.
6
Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.人正常、增生及肿瘤性前列腺组织中转化生长因子α、表皮生长因子及表皮生长因子受体的免疫组织化学对比分析
Cytokine. 1999 Sep;11(9):722-7. doi: 10.1006/cyto.1998.0443.
7
Transforming growth factor-beta expression in prostate neoplasia.前列腺肿瘤中转化生长因子-β的表达
Anal Quant Cytol Histol. 2000 Feb;22(1):1-10.
8
Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.转化生长因子-β诱导前列腺基质细胞生长抑制及胰岛素样生长因子结合蛋白-3生成:良性前列腺增生组织培养细胞中的异常情况。
J Endocrinol. 2000 Feb;164(2):215-23. doi: 10.1677/joe.0.1640215.
9
Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.c-kit和kit配体在前列腺良恶性组织中的表达。
Histol Histopathol. 2000 Apr;15(2):365-74. doi: 10.14670/HH-15.365.
10
Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.正常和异常前列腺生长过程中的间充质-上皮相互作用及转化生长因子-β1表达
Microsc Res Tech. 1995 Mar 1;30(4):333-41. doi: 10.1002/jemt.1070300408.

引用本文的文献

1
A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer.去势抵抗性前列腺癌潜在病理生理机制综述
Res Rep Urol. 2021 Jun 30;13:457-472. doi: 10.2147/RRU.S264722. eCollection 2021.
2
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.人类前列腺癌的差异表达基因和标志性通路
PLoS One. 2015 Dec 18;10(12):e0145322. doi: 10.1371/journal.pone.0145322. eCollection 2015.
3
A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential.
探索具有从实验室到临床应用潜力的前列腺癌循环生物标志物
J Biomark. 2014;2014:321680. doi: 10.1155/2014/321680. Epub 2014 Mar 12.
4
Novel tools for prostate cancer prognosis, diagnosis, and follow-up.用于前列腺癌预后、诊断和随访的新型工具。
Biomed Res Int. 2014;2014:890697. doi: 10.1155/2014/890697. Epub 2014 May 4.
5
Emerging roles of human prostatic Acid phosphatase.人前列腺酸性磷酸酶的新作用
Biomol Ther (Seoul). 2013 Jan;21(1):10-20. doi: 10.4062/biomolther.2012.095.
6
PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.过氧化物酶体增殖物激活受体 δ 通过激活 ABCA1-Cav1 通路促进 TGF-β1 信号的致癌重定向。
Cell Cycle. 2013 May 15;12(10):1521-35. doi: 10.4161/cc.24636. Epub 2013 Apr 17.
7
The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.TGFβ1 和 IL-7 对预测前列腺癌进展过程的附加价值。
Cancer Immunol Immunother. 2012 Jun;61(6):905-10. doi: 10.1007/s00262-011-1159-3. Epub 2011 Nov 24.
8
Tumor markers in prostate cancer I: blood-based markers.前列腺癌的肿瘤标志物 I:基于血液的标志物。
Acta Oncol. 2011 Jun;50 Suppl 1(Suppl 1):61-75. doi: 10.3109/0284186X.2010.542174.
9
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.超越前列腺特异性抗原:用于改善前列腺癌诊断和管理的新型血清生物标志物。
Rev Urol. 2004 Spring;6(2):58-72.
10
Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.转化生长因子-β抑制剂逆转肿瘤诱导的免疫抑制作用
Invest New Drugs. 2003 Feb;21(1):21-32. doi: 10.1023/a:1022951824806.